Abrilada Kit
Product Images NDC 50090-7998

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Abrilada (NDC 50090-7998). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Abrilada 01)

A line graph showing the percentage of ACR20 responders over time in weeks. The graph compares two treatments: 40 mg every other week (solid line with square markers) and placebo (dashed line with circle markers). The 40 mg treatment shows a higher and sustained response rate compared to placebo throughout 48 weeks.*

FDA Label Image

Figure 2 (Abrilada 02)

A line graph showing the percentage of ASAS 20 response over time in weeks for two groups: placebo (dashed line with open circles) and adalimumab (solid line with filled squares). The adalimumab group shows a higher and more sustained response rate across 24 weeks compared to placebo.*

FDA Label Image

Study Uv I (Abrilada 02a)

A line graph presenting treatment failure rates over time in months, comparing placebo and adalimumab. The graph shows treatment failure rate percentages on the vertical axis and time in months on the horizontal axis, illustrating different outcomes between the placebo and adalimumab groups.*

FDA Label Image

Study Uv Ii (Abrilada 02b)

A line graph showing treatment failure rate (%) over time (months) comparing placebo and adalimumab treatment groups. The x-axis represents duration of treatment in months up to 20 months, and the y-axis represents the treatment failure rate percentage from 0 to 100%. Two lines illustrate different failure rates for placebo and adalimumab groups over the treatment period.*

FDA Label Image

Pfizer (Abrilada 03)

FDA Label Image

Pfizer (Abrilada 04)

FDA Label Image

Step 3 (Abrilada 05)

Instructional illustration showing Step 3 of a medication usage guide, focusing on checking the medicine and its expiration date on a device or packaging. A hand is pointing to an area magnified for clarity, indicating where to verify these details.*

FDA Label Image

Image (Abrilada 06)

An illustrated diagram of the ABRILADA (adalimumab-afzb) auto-injector pen shows labeled parts: the cap, window, injection button, and an inset highlighting the location of the expiration date on the side of the pen. The drawing helps identify functional components of the auto-injector kit.*

FDA Label Image

Step 4 (Abrilada 07)

An instructional illustration showing Step 4 for preparing an injection site for the ABRILADA kit. It depicts a human torso and upper thighs with shaded areas indicating injection sites: the abdomen should be at least 2 inches (5 cm) away from the belly button, and the front upper thigh is also indicated as an injection site.*

FDA Label Image

Step 5 (Abrilada 08)

An instructional illustration depicting Step 5 of a process for using the ABRILADA (adalimumab-afzb) kit. It shows a hand removing the cap from a device by pulling it outward, indicated by a red arrow, as part of medication preparation.*

FDA Label Image

C:\temp\pfizer Oct 4\attached File _1664891496641_2578536_2022_09_20_81a33cfa-262f_11027\abrilada-09.jpg (Abrilada 09)

Instructional illustration labeled Step 6 showing how to insert the needle for use with ABRILADA (adalimumab-afzb) kit. It depicts a hand holding the syringe or pen, pushing down to insert the needle into the skin, indicated by arrows and close-up images of needle positioning.*

FDA Label Image

Step 7 (Abrilada 10)

An instructional illustration demonstrating Step 7 for injecting medicine using a device. It shows pressing the device until a first click, keeping it held in place with a second click indication, and then waiting while holding for 5 more seconds before removal.*

FDA Label Image

Step 8 (Abrilada 11)

Instructional illustration labeled Step 8 showing a hand holding a syringe-like device with a zoomed-in view of a window on the device indicating the need to check the window. The image likely relates to the usage instructions for the ABRILADA kit by A-S Medication Solutions.*

FDA Label Image

Step 9 (Abrilada 12)

Instructional illustration showing Step 9 for the ABRILADA (adalimumab-afzb) kit, depicting a hand gripping a pen device and removing the pen by pulling it upward, indicated by a red arrow.*

FDA Label Image

Step 10 (Abrilada 13)

Instructional illustration showing Step 10 in the disposal process for the ABRILADA pen. The image depicts a hand placing a used injection pen into a sharps disposal container labeled as "Dispose of used pen."*

FDA Label Image

Step 11 (Abrilada 14)

Instructional illustration showing a hand wiping an injection site with a cotton ball or gauze, labeled as Step 11 in a sequence related to injection procedures.*

FDA Label Image

Image (Abrilada 15)

Illustration showing two methods for preparing an injection site on the abdomen: the stretch method with fingers pulling the skin taut horizontally, and the pinch method with fingers lifting a fold of abdominal skin vertically.*

FDA Label Image

Pfizer (Abrilada 16)

FDA Label Image

Image (Abrilada 17)

An instructional diagram showing a syringe labeled with parts including the plunger rod, barrel, window, and needle cover. The image highlights the location of the expiration date on the syringe barrel, indicating where to find the date printed in year, month, and day format.*

FDA Label Image

Step 3 (Abrilada 18)

Instructional illustration showing Step 3 to unpack a prefilled syringe from the kit. It depicts a hand removing the syringe from its plastic tray, with a red arrow pointing upward indicating the direction to lift the syringe.*

FDA Label Image

Step 4 (Abrilada 19)

An instructional illustration showing Step 4: check your medicine and expiration date. The image depicts a hand holding a syringe or injection device with an area highlighted to indicate where to find the medicine and expiration date information.*

FDA Label Image

Step 5 (Abrilada 20)

Instructional illustration from ABRILADA (adalimumab-afzb) kit showing Step 5 on choosing and preparing the injection site. The image depicts a human figure highlighting the abdomen area, advising to keep at least 2 inches (5 cm) away from the belly button, and the front upper thigh as appropriate injection sites.*

FDA Label Image

Step 6 (Abrilada 21)

Illustration showing step 6 of a medication preparation process, where a person is removing the needle cover from a syringe. The image highlights the correct hand positioning and an upward arrow indicating the direction to pull the needle cover off.*

FDA Label Image

Step 7 (Abrilada 22)

Instructional diagram titled 'Step 7 Insert the needle' showing a hand holding a syringe at a 45-degree angle to insert the needle into the skin of a finger on the opposite hand. This illustrates part of the injection process for the ABRILADA kit.*

FDA Label Image

Step 8 (Abrilada 23)

An instructional illustration showing Step 8 for the ABRILADA kit, demonstrating how to inject the medicine. The image depicts a hand holding a syringe with an arrow pointing to the injection area where the needle is inserted into the skin.*

FDA Label Image

Step 9 (Abrilada 24)

An instructional illustration showing a hand holding a syringe with a needle, accompanied by the text 'Step 9 Check your syringe' above the image. The syringe is displayed in close-up with a circular highlight around the needle area.*

FDA Label Image

Step 10 (Abrilada 25)

An instructional diagram labeled Step 10 showing a hand disposing of a used syringe into a sharps container. The hand holds the syringe over the container's opening, emphasizing safe disposal practices for syringes as part of the ABRILADA (adalimumab-afzb) kit use instructions.*

FDA Label Image

Step 11 (Abrilada 26)

An instructional illustration labeled 'Step 11 After' depicts a hand wiping a surface or area with a round cotton or cloth pad. The image is part of a multi-step procedure, focusing on the action of cleaning or applying after a prior step.*

FDA Label Image

Pfizer (Abrilada 27)

FDA Label Image

Label Image (Lbl500907998)

Packaging label for ABRILADA (adalimumab-afzb) 40 mg/0.8 mL kit by A-S Medication Solutions. The label indicates a citrate-free solution with each kit containing 2 single-dose prefilled pens and 29 gauge needles. Distributed by A-S Medication Solutions in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.